Journal of Chinese Integrative Medicine ›› 2008, Vol. 6 ›› Issue (11): 1164-1169.doi: 10.3736/jcim20081111
• Original Experimental Research • Previous Articles Next Articles
Min Li1, Qing Ni2, Xiao-yan Chu2, Zhao-li Wang2, Lan Lin2(
)
CLC Number:
| [1] |
Huang B, Liu XZ, Pang DB . Study on diabetic model in rats induced by streotozotocin in different ways[J]. Jinzhou Yi Xue Yuan Xue Bao, 2003,24(1):19-21
doi: 10.3969/j.issn.1674-0424.2003.01.006 |
|
黄波, 刘学政, 庞东渤 . 不同途径注射链脲佐菌素致大鼠糖尿病模型的研究[J]. 锦州医学院学报, 2003,24(1):19-21
doi: 10.3969/j.issn.1674-0424.2003.01.006 |
|
| [2] |
McDonald KM, Garr M, Carlyle PF , et al. Relative effects of alpha 1-adrenoceptor blockade, converting enzyme inhibitor therapy, and angiotensin Ⅱ subtype 1 receptor blockade on ventricular remodeling in the dog[J]. Circulation, 1994,90(6):3034-3046
doi: 10.1161/01.CIR.90.6.3034 |
| [3] |
Metsarinne KP, Helin KH, Saijonmaa O , et al. Tissue-specific regulation of angiotensin-converting enzyme by angiotensin Ⅱ and losartan in the rat[J].Blood Press, 1996,5(6):363-370
doi: 10.3109/08037059609078076 |
| [4] |
Haywood GA, Gullestad L, Katsuya T , et al. AT1 and AT2 angiotensin receptor gene expression in human heart failure[J]. Circulation, 1997,95(5):1201-1206
doi: 10.1161/01.CIR.95.5.1201 |
| [5] |
Jennings G . New definitions in cardiovascular risk management: is it time for angiotensin Ⅱ receptor blockers to become first-line medication?[J]. Eur Heart J Suppl, 2003,5(Suppl F):F3-F11
doi: 10.1016/S1520-765X(03)90010-1 |
| [6] |
Kaprielian RR, Dupont E, Hafizi S , et al. Angiotensin Ⅱ receptor type 1 mRNA is unregulated in atria of patients with end-stage heart failure[J]. J Mol Cell Cardiol, 1997,29(8):2299-2304
doi: 10.1006/jmcc.1997.0458 |
| [7] |
Clozcl M, Kuhn H, Hefti F . Effects of angiotensin converting enzyme inhibitors and of hydralazine on endothelial function in hypertensive rats[J]. Hypertension, 1990,16(5):532-540
doi: 10.1161/01.HYP.16.5.532 |
| [8] |
Kajstura J, Fiordaliso F, Andreoli AM , et al. IGF-1 overexpression inhibits the development of diabetic cardiomyopathy and angiotensin Ⅱ-mediated oxidative stress[J]. Diabetes, 2001,50(6):1414-1424
doi: 10.2337/diabetes.50.6.1414 |
| [9] |
Fiordaliso F, Li B, Latini R , et al. Myocyte death in streptozotocin-induced diabetes in rats in angiotensin Ⅱ-dependent[J]. Lab Invest, 2000,80(4):513-527
doi: 10.1038/labinvest.3780057 pmid: 10780668 |
| [10] |
Jing YL, Tian H, Pan CY , et al. The effect of angiotensin Ⅱ on cardiomyopathy of STZ diabetic rats and the protective effect of captopril[J]. Zhongguo Tang Niao Bing Za Zhi, 2000,8(5):298-300
doi: 10.3321/j.issn:1006-6187.2000.05.013 |
|
景雅莉, 田慧, 潘长玉 , 等. 血管紧张素Ⅱ对实验性糖尿病大鼠心肌病变的影响及卡托普利的保护作用[J]. 中国糖尿病杂志, 2000,8(5):298-300
doi: 10.3321/j.issn:1006-6187.2000.05.013 |
|
| [11] |
Yang J, Xue C, Hu G . Effects of enalapril on plasma Ang Ⅱ level and the expression of AT1 in blood vessel and kidney of type 2 diabetic rats[J]. Yao Xue Xue Bao, 2005,40(3):208-212
doi: 10.3321/j.issn:0513-4870.2005.03.004 |
|
杨俭, 薛春, 胡刚 . 依那普利对2型糖尿病大鼠血浆Ang Ⅱ水平及血管、肾脏AT1受体表达的影响[J]. 药学学报, 2005,40(3):208-212
doi: 10.3321/j.issn:0513-4870.2005.03.004 |
|
| [12] | Shi ZM, Qian XM, Xu RJ , et al. A study of angiotensin-Ⅱ and myocardial ultrastructure in experimental diabetic rats[J]. Zhongguo Tang Niao Bing Za Zhi, 1996,4(1):28-30 |
| 施志明, 钱晓明, 许瑞吉 , 等. 实验性糖尿病大鼠心肌ATⅡ和心肌超微结构的研究[J]. 中国糖尿病杂志, 1996,4(1):28-30 |
|